chr4-186079310-A-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003265.3(TLR3):c.633+279A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0388 in 152,300 control chromosomes in the GnomAD database, including 241 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.039   (  241   hom.,  cov: 32) 
Consequence
 TLR3
NM_003265.3 intron
NM_003265.3 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -1.19  
Publications
6 publications found 
Genes affected
 TLR3  (HGNC:11849):  (toll like receptor 3) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This receptor is most abundantly expressed in placenta and pancreas, and is restricted to the dendritic subpopulation of the leukocytes. It recognizes dsRNA associated with viral infection, and induces the activation of NF-kappaB and the production of type I interferons. It thus plays a role in host defense against multiple viruses. [provided by RefSeq, Jul 2021] 
TLR3 Gene-Disease associations (from GenCC):
- immunodeficiency 83, susceptibility to viral infectionsInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89). 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0983  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| TLR3 | ENST00000296795.8  | c.633+279A>G | intron_variant | Intron 3 of 4 | 1 | NM_003265.3 | ENSP00000296795.3 | |||
| TLR3 | ENST00000513189.1  | n.633+279A>G | intron_variant | Intron 3 of 4 | 1 | ENSP00000423386.1 | ||||
| TLR3 | ENST00000698351.1  | c.633+279A>G | intron_variant | Intron 3 of 4 | ENSP00000513674.1 | |||||
| TLR3 | ENST00000698352.1  | n.*185+279A>G | intron_variant | Intron 3 of 4 | ENSP00000513675.1 | 
Frequencies
GnomAD3 genomes   AF:  0.0387  AC: 5894AN: 152182Hom.:  239  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
5894
AN: 
152182
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.0388  AC: 5903AN: 152300Hom.:  241  Cov.: 32 AF XY:  0.0371  AC XY: 2766AN XY: 74474 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
5903
AN: 
152300
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
2766
AN XY: 
74474
show subpopulations 
African (AFR) 
 AF: 
AC: 
4190
AN: 
41556
American (AMR) 
 AF: 
AC: 
434
AN: 
15292
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
116
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
1
AN: 
5184
South Asian (SAS) 
 AF: 
AC: 
18
AN: 
4826
European-Finnish (FIN) 
 AF: 
AC: 
77
AN: 
10620
Middle Eastern (MID) 
 AF: 
AC: 
36
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
923
AN: 
68032
Other (OTH) 
 AF: 
AC: 
70
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.507 
Heterozygous variant carriers
 0 
 275 
 549 
 824 
 1098 
 1373 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 56 
 112 
 168 
 224 
 280 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
45
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.